DE60316714D1 - Pharmazeutische formulierung enthaltend olanzapin - Google Patents

Pharmazeutische formulierung enthaltend olanzapin

Info

Publication number: DE60316714D1
Authority: DE; Germany
Prior art keywords: pharmaceutical formulation; formulation containing; containing olanzapine; olanzapine; monosaccharide
Prior art date: 2002-10-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60316714T

Other languages

English (en)

Other versions

DE60316714T2 (de

Inventor

Stanka Perc

Ivanka Banko

Ivanka Kolenc

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

KRKA dd

Original Assignee

KRKA Tovarna Zdravil dd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-18

Filing date

2003-10-16

Publication date

2007-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32173824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60316714(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-16 Application filed by KRKA Tovarna Zdravil dd filed Critical KRKA Tovarna Zdravil dd

2007-11-15 Publication of DE60316714D1 publication Critical patent/DE60316714D1/de

2008-07-17 Application granted granted Critical

2008-07-17 Publication of DE60316714T2 publication Critical patent/DE60316714T2/de

2023-10-17 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DE60316714T 2002-10-18 2003-10-16 Pharmazeutische formulierung enthaltend olanzapin Expired - Lifetime DE60316714T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SI200200255		2002-10-18
SI200200255A SI21303A (sl)	2002-10-18	2002-10-18	Farmacevtska formulacija olanzapina
PCT/SI2003/000036 WO2004035027A1 (en)	2002-10-18	2003-10-16	Pharmaceutical formulation of olanzapine

Publications (2)

Publication Number	Publication Date
DE60316714D1 true DE60316714D1 (de)	2007-11-15
DE60316714T2 DE60316714T2 (de)	2008-07-17

Family

ID=32173824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60316714T Expired - Lifetime DE60316714T2 (de)	2002-10-18	2003-10-16	Pharmazeutische formulierung enthaltend olanzapin

Country Status (18)

Country	Link
US (2)	US20050288276A1 (de)
EP (1)	EP1558219B1 (de)
AT (1)	ATE374600T1 (de)
AU (1)	AU2003269792A1 (de)
CA (1)	CA2502582C (de)
CY (1)	CY1107819T1 (de)
DE (1)	DE60316714T2 (de)
DK (1)	DK1558219T3 (de)
EA (1)	EA008516B1 (de)
ES (1)	ES2295626T3 (de)
HR (1)	HRP20050342B1 (de)
NO (1)	NO20052408L (de)
PL (1)	PL206217B1 (de)
PT (1)	PT1558219E (de)
RS (1)	RS51488B (de)
SI (2)	SI21303A (de)
UA (1)	UA89349C2 (de)
WO (1)	WO2004035027A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1778183B1 (de) *	2004-08-18	2018-06-27	Synthon B.V.	Flüssige paroxetinzusammensetzungen
CZ200563A3 (cs) *	2005-02-02	2006-10-11	Zentiva, A. S.	Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
GB0522474D0 (en) *	2005-11-03	2005-12-14	Actavis Group	A pharmaceutical formulation
GB0522473D0 (en) *	2005-11-03	2005-12-14	Actavis Group	A pharmaceutical formulation
ES2279715B1 (es)	2005-12-26	2008-06-01	Laboratorios Lesvi, S.L.	Formulacion oral de olanzapina.
WO2007134845A2 (en) *	2006-05-18	2007-11-29	Synthon B.V.	Olanzapine pharmaceutical composition
US20080138409A1 (en) *	2006-09-29	2008-06-12	Osinga Niels J	Olanzapine pharmaceutical composition
WO2012014012A1 (es) *	2010-07-27	2012-02-02	Laboratorios Andrómaco S.A.	Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia.
WO2012153347A2 (en)	2011-05-04	2012-11-15	Zentiva K.S.	Oral pharmaceutical composition of olanzapine form 1
WO2013066280A1 (en) *	2011-10-31	2013-05-10	Mahmut Bilgic	Water soluble antipsychotic formulations
CN103919782B (zh) *	2013-01-15	2016-12-28	天津药物研究院有限公司	一种含有奥氮平的药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2115116C3 (de) *	1970-03-27	1982-04-15	Sankyo Co., Ltd., Tokyo	Gleitmittel und Verfahren zu dessen Herstellung
US5229382A (en) *	1990-04-25	1993-07-20	Lilly Industries Limited	2-methyl-thieno-benzodiazepine
GB9009229D0 (en)	1990-04-25	1990-06-20	Lilly Industries Ltd	Pharmaceutical compounds
TR199900651T2 (xx) *	1996-09-24	1999-07-21	Eli Lilly And Company	Kaplanm�� par�ac�k form�lasyonu.
US6348458B1 (en) *	1999-12-28	2002-02-19	U & I Pharmaceuticals Ltd.	Polymorphic forms of olanzapine
US6906062B2 (en) *	2001-12-24	2005-06-14	Sun Pharmaceutical Industries Limited	Crystalline form I of 2-methyl-4-(4-menthyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
AU2002255196A1 (en) *	2002-04-18	2003-10-27	Dr. Reddy's Laboratories Ltd.	Rapidly dispersing solid oral compositions

2002
- 2002-10-18 SI SI200200255A patent/SI21303A/sl not_active IP Right Cessation
2003
- 2003-10-16 RS YUP-2005/0292A patent/RS51488B/en unknown
- 2003-10-16 WO PCT/SI2003/000036 patent/WO2004035027A1/en active IP Right Grant
- 2003-10-16 EP EP03751723A patent/EP1558219B1/de not_active Revoked
- 2003-10-16 DK DK03751723T patent/DK1558219T3/da active
- 2003-10-16 AT AT03751723T patent/ATE374600T1/de active
- 2003-10-16 EA EA200500671A patent/EA008516B1/ru not_active IP Right Cessation
- 2003-10-16 PL PL376413A patent/PL206217B1/pl unknown
- 2003-10-16 DE DE60316714T patent/DE60316714T2/de not_active Expired - Lifetime
- 2003-10-16 US US10/531,540 patent/US20050288276A1/en not_active Abandoned
- 2003-10-16 SI SI200331001T patent/SI1558219T1/sl unknown
- 2003-10-16 UA UAA200504641A patent/UA89349C2/uk unknown
- 2003-10-16 AU AU2003269792A patent/AU2003269792A1/en not_active Abandoned
- 2003-10-16 ES ES03751723T patent/ES2295626T3/es not_active Expired - Lifetime
- 2003-10-16 CA CA2502582A patent/CA2502582C/en not_active Expired - Fee Related
- 2003-10-16 PT PT03751723T patent/PT1558219E/pt unknown
2005
- 2005-04-15 HR HRP20050342AA patent/HRP20050342B1/hr not_active IP Right Cessation
- 2005-05-13 NO NO20052408A patent/NO20052408L/no not_active Application Discontinuation
2007
- 2007-12-03 CY CY20071101537T patent/CY1107819T1/el unknown
2011
- 2011-09-08 US US13/228,028 patent/US20110319395A1/en not_active Abandoned

Also Published As

Publication number	Publication date
UA89349C2 (uk)	2010-01-25
PL206217B1 (pl)	2010-07-30
SI1558219T1 (sl)	2008-02-29
US20050288276A1 (en)	2005-12-29
CY1107819T1 (el)	2013-06-19
EA008516B1 (ru)	2007-06-29
AU2003269792A1 (en)	2004-05-04
PL376413A1 (en)	2005-12-27
CA2502582A1 (en)	2004-04-29
EA200500671A1 (ru)	2005-10-27
HRP20050342B1 (hr)	2013-11-08
DK1558219T3 (da)	2007-10-29
SI21303A (sl)	2004-04-30
RS51488B (en)	2011-04-30
HRP20050342A2 (hr)	2006-04-30
RS20050292A (en)	2007-08-03
NO20052408L (no)	2005-07-04
WO2004035027A1 (en)	2004-04-29
EP1558219B1 (de)	2007-10-03
DE60316714T2 (de)	2008-07-17
ES2295626T3 (es)	2008-04-16
US20110319395A1 (en)	2011-12-29
ATE374600T1 (de)	2007-10-15
NO20052408D0 (no)	2005-05-13
EP1558219A1 (de)	2005-08-03
CA2502582C (en)	2010-08-03
PT1558219E (pt)	2008-01-04

Publication	Publication Date	Title
CY1107819T1 (el)	2013-06-19	Φαρμακευτικη διαμορφωση της ολανζαπινης
NO20062504L (no)	2006-07-21	Sammensetninger og doseringsformer for forbedret absorpsjon
DK1207756T3 (da)	2006-08-14	Anvendelse af spinosad eller en formulering, der omfatter spinosad
EP1589947B8 (de)	2016-08-24	Pharmazeutische formulierung enthaltend einen unlöslichen wirkstoff zur pulmonalen verabreichung
EP1483277A4 (de)	2007-10-03	Konjugate biologisch aktiver verbindungen, verfahren zu deren herstellung und anwendung, formulierung und pharmazeutische anwendungen davon
EE05383B1 (et)	2011-02-15	Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
DE60312523D1 (de)	2007-04-26	Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
AU2003215245A1 (en)	2003-09-09	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
ATE292453T1 (de)	2005-04-15	Antivirale arznei
NO20034863L (no)	2003-12-30	Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
WO2005065639A3 (en)	2005-09-01	Novel pharmaceutical compositions
WO2002015933A3 (en)	2003-08-14	Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
WO2004069187A3 (en)	2005-03-31	Drug formulation and delivery using crystalline methylated cyclodextrins
EA200601015A1 (ru)	2006-10-27	Пероральные композиции дезоксипеганина и их применение
BR0007513A (pt)	2001-11-20	Fosfatidilinositóis sulfatados, sua preparação euso
WO2004033484A3 (en)	2004-06-10	Use of stable glutamine derivatives to improve drug absorption
AU2001260089A1 (en)	2001-12-03	Pharmaceutical compositions comprising desglymidodrine as an active drug substance
BR0202759A (pt)	2004-05-11	Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
BR0316486A (pt)	2005-10-11	Composição farmacêutica que compreende um antagonista do ltb4 e um inibidor da cox-2 ou um inibidor combinado da cox1/2
IL163552A0 (en)	2005-12-18	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof

Legal Events

Date	Code	Title	Description
2008-09-18	8363	Opposition against the patent